Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Two River is a venture capital firm and merchant bank founded in 2004, primarily based out of New York City, United States. It specializes in investments in life science, biotechnology, and firms focused on developing preventative and therapeutic technologies for a broad spectrum of disease areas including oncology, cardiovascular disease, neurological disorders, and companion animal health care. Two River has invested in companies across the United States and Israel.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Two River's primary sector focus for investments?
- Two River primarily focuses its investments in the Health Tech & Life Sciences sector, as evidenced by its portfolio company UroGen Pharma.
- Can you name a notable exit for Two River?
- Two River had a notable exit with UroGen Pharma, which went public on NASDAQ in May 2017 with a valuation of $155.6M.
- What is the funding stage Two River typically invests in?
- Two River has participated in A Round funding stages, as seen with its investment in UroGen Pharma in November 2015.
- What is the total capital raised by UroGen Pharma, a Two River portfolio company, prior to its IPO?
- UroGen Pharma, a Two River portfolio company, raised $58.2M in capital prior to its IPO in May 2017.
- When did Two River make its investment in UroGen Pharma?
- Two River made an investment in UroGen Pharma in November 2015.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2004 |
|---|
Radar intelligence
Patents
| EPO | 81 |
|---|